Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer

Carcinogenesis

Volumn 27, Issue 8, 2006, Pages 1547-1555

  Stabile, Laura P ^a,c   Lyker, Jennifer S ^a   Land, Stephanie R ^b,c   Dacic, Sanja ^a,c   Zamboni, Beth A ^b   Siegfried, Jill M ^a,c  

^a Department of Pharmacology ^*  (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANTINEOPLASTIC AGENT; CARCINOGEN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SODIUM CHLORIDE;

AIRWAY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DRUG TARGETING; EXPOSURE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; RESPIRATORY EPITHELIUM; TISSUE SECTION; TOBACCO; TRANSGENE; TRANSGENIC MOUSE; TUMOR VOLUME; WILD TYPE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANIMALS; CARCINOGENS; DISEASE SUSCEPTIBILITY; EPITHELIUM; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; NITROSAMINES; RESPIRATORY MUCOSA;

EID: 33747871434     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl003     Document Type: Article

References (54)

1. American Cancer Society. (2004) Cancer facts and figures. In Surveillance Research. American Cancer Society, Atlanta, GA, pp. 1-60.
2. Nakamura,T., Nawa,K. and Icihara,A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun., 12, 1450-1459.
3. Weidner,K.M., Behrens,J., Vandekerckhove,J. and Birchmeier,W. (1990) Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell. Biol., 11, 2097-2108.
4. Rong,S., Bodescot,M., Blair,D., Dunn,J., Nakamura,T., Mizuno,K., Park,M., Chan,A., Aaronson,S. and Vande Woude,G.F. (1992) Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol., 12, 5152-5158.
5. Rosen,E.M., Meromsky,L., Setter,E., Vinter,D.W. and Goldberg,I.D. (1990) Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis, 10, 49-64.
6. Tsao,M.S., Zhu,H., Giaid,A., Viallet,J., Nakamura,T. and Park,M. (1993) Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ., 4, 571-579.
7. Yoshinaga,Y., Matsuno,Y., Fujita,S., Nakamura,T., Kikuchi,M., Shimosato,Y. and Hirohashi,S. (1993) Human lung cancer cell line producing hepatocyte growth factor/scatter factor. Jpn. J. Cancer Res., 84, 1150-1158.
8. Tokunou,M., Niki,T., Eguchi,K. et al. (2001) c-MET expression in myofibroblasts: Role in autocrine activation and prognostic significance in lung adenocarcinoma. Am. J. Pathol., 158, 1451-1463.
9. Yi,S. and Tsao,M.S. (2000) Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia, 2, 226-234.
10. Pilewski,J.M., Bumbalo,T., Davis,A.G. and Siegfried,J.M. (2001) Hepatocyte growth factor promotes tumor growth in a novel in vivo model of human lung cancer. Am. J. Respir. Mol. Cell. Biol., 24, 556-562.
11. Siegfried,J.M., Luketich,J.D, Stabile,L.P., Christie,N. and Land,S.R. (2004) Elevated hepatocyte growth factor level correlates with poor outcome in early and late stage adenocarcinoma of the lung. Chest, 125, 116S-119S.
12. Stabile,L.P., Lyker,J.S., Huang,L. and Siegfried,J.M. (2004) Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy. Gene Ther., 11, 325-335.
13. Maulik,G., Kijima,T., Ma,P.C., Ghosh,S.K., Lin,J., Shapiro,G.I., Schaefer,E., Tibaldi,E., Johnson,B.E. and Salgia,R. (2002) Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Clin. Cancer Res., 8, 620-627.
14. Bell,A., Chen,Q., DeFrances,M.C., Micalopoulos,G.K. and Zarnegar,R. (1999) The five amino-acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Oncogene, 18, 887-895.
15. Beier,H.M., Kirchner,C. and Mootz,M. (1978) Uteroglobin-like antigen in the pulmonary epithelium and secretion of the lung. Cell Tissue Res., 190, 15-25.
16. Krishnan,R.S. and Daniel,J.C.,Jr (1967) 'Blastokinin': Inducer and regulator of blastocyst development in the rabbit uterus. Science, 158, 490-492.
17. Singh,G. and Katyal,S.L. (1997) Clara cells and clara cell 10 kDa protein (CC10). Am. J. Respir. Cell Mol. Biol., 17, 141-143.
18. Hackett,B. and Gitlin,J.D. (1992) Cell specific expression of a Clara cell secretory protein-human growth hormone gene in the bronchiolar epithelium of transgenic mice. Proc. Natl Acad. Sci. USA, 89, 9079-9083.
19. Singh-Kaw,P, Zarnegar,R. and Siegfried,J.M. (1995) Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. Am. J. Physiol., 268, L1012-L1020.
20. Yanagita,K., Nagaike,M., Ishibashi,H., Niho,Y., Matsumoto,K. and Nakamura,T. (1992) Lung may have an endocrine function producing hepatocyte growth factor in response to injury to distal organs. Biochem. Biophys. Res. Commun., 182, 802-809.
21. Selden,R.F., Howie,K.B., Rowe,M.E., Goodman,H.M. and Moore,D.D. (1986) Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol., 6, 3173-3179.
22. Stabile,L.P., Gaither Davis,A.L., Gubish,C.T., Hopkins,T.M., Luketich,J.D., Christie,N., Finkelstein,S. and Siegfried,J.M. (2002) Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor a and b and show biological responses to estrogen. Cancer Res., 62, 2141-2150.
23. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-9.
24. Church,G.M. and Gilbert,W. (1984) Genomic sequencing. Proc. Natl Acad. Sci. USA, 81, 1991-1995.
25. Amasino,R.M. (1986) Acceleration of nucleic acid hybridization rate by polyethylene glycol. Anal. Biochem., 152, 304-307.
26. Mahler,J.F., Stokes,W., Mann,P.C., Takaoka,M. and Maronpot,R.R. (1996) Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol., 24, 710-716.
27. Yamanouchi,H., Fujita,J., Yoshinouchi,T., Hojo,S., Kamei,T., Yamadori,I., Ohtsuki,Y., Ueda,N. and Takahara,J. (1998) Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Respir. Med., 92, 273-278.
28. Ohmichi,H., Koshimizu,U., Matsumoto,K. and Nakamura,T. (1998) Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development, 125, 1315-1324.
29. Belinsky,S.A., Devereux,T.R., Maronpot,R.R., Stoner,G.D. and Anderson,M. (1989) Relationship between the formation of promutagenic adducts and the activation of the K-ras proto-oncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res., 49, 5305-5311.
30. Tchou-Wong,K.M., Jiang,Y., Yee,H., LaRosa,J., Lee,T.C., Pellicer,A., Jagirdar,J., Gordon,T., Goldberg,J.D. and Rom,W.N. (2002) Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer. Am. J. Respir. Cell Mol. Biol., 27, 186-193.
31. Lee,J.J., McGarry,M.P., Farmer,S.C. et al. (1997) Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomic of asthma. J. Exp. Med., 185, 2143-2156.
32. Dhami,R., Zay,K., Gilks,B., Porter,S., Wright,J.L. and Churg,A. (1999) Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium. J. Mol. Med., 77, 377-385.
33. Ichimura,E., Maeshima,A., Nakajima,T. and Nakamura,T. (1996) Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. Jpn. J. Cancer Res., 87, 1063-1069.
34. Harvey,P., Warn,A., Newman,P., Perry,L.J., Ball,R.Y. and Warn,R.M. (1996) Immunoreactivity for hepatocyte growth factor and its receptor, met, in human lung carcinomas and malignant mesothelioma. J. Pathol., 180, 389-394.
35. Takanami,I., Tanana,F., Hashizume,T., Kikuchi,K., Yamamoto,Y., Yamamoto,T. and Kodaira,S. (1996) Hepatocyte growth factor and c-Met/ hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers. Oncology, 53, 392-397.
36. Masuya,D., Huang,C., Liu,D., Nakashima,T., Kameyama,K., Haba,R., Ueno,M. and Yokomise,H. (2004) The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small cell lung cancer patients. Br. J. Cancer, 90, 1555-1562.
37. Sheen-Chen,S.-M., Liu,Y.-W., Eng,H-L. and Chou,F.-F. (2005) Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiol. Biomarkers Prev., 14, 715-717.
38. Bharti,A., Ma,P.C., Maulik,G., Singh,R., Khan,E. and Skarin,A.T. (2004) Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res., 24, 1031-1038.
39. Takayama,H., LaRochelle,W., Sharp,R., Otsuka,T., Kriebel,P., Anver,M., Aaronson,S.A. and Merlino,G. (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl Acad. Sci. USA, 94, 701-706.
40. Horiguchi,N., Takayama,H., Toyoda,M., Otsuka,T., Fukusato,T., Merlino,G., Takagi,H. and Mori,M. (2002) Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene, 21, 1791-1799.
41. Zhang,Y.W., Su,Y., Lanning,N., Gustafson,M., Shinomiya,N., Zhao,P., Cao,B., Tsarfaty,G., Wang,L.M., Hay,R. and Vande Woude,G.F. (2005) Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/ scatter factor. Oncogene, 24, 101-106.
42. Takayama,H., LaRochelle,W., Sabnis,G.S., Otsuka,T. and Merlino,G. (1997) Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest., 77, 131-138.
43. Frankel,S.K., Moats-Staats,B.M., Cool,C.D., Wynes,M.W., Stiles,A.D. and Riches,D.W. (2005) Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol., 288, L805-L812.
44. Christensen,J.G., Schreck,R., Burrows,J. et al. (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res., 63, 7345-7355.
45. Ma,P.C., Jagadeeswaran,R., Jagadeesh,S. et al. (2005) Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res., 65, 1479-1488.
46. Kim,K.J., Wang,L, Su,Y.-C., Gillespie,G.Y., Salhotra,A., Lal,B. and Laterra,J. (2006) Systemic anti-HGF monoclonal antibody therapy induces regression of intracranial glioma xenografts. Clin. Cancer Res., 12, 1292-1298.
47. Cao,B., Su,Y., Oskarsson,M., Zhao,P., Kort,E.J., Fisher,R.J., Wang,L.M. and Vande Woude,G.F. (2001) Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl Acad. Sci. USA, 98, 7443-7448.
48. Matsumoto,K. and Nakamura,T. (2003) NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci., 94, 321-327.
49. Abounader,R., Ranganathan,S., Lal,B., Fielding,K., Book,A., Dietz,H., Burger,P. and Laterra,J. (1999) Reversion of human gliobastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/ hepatocyte growth factor and c-met expression. J. Natl Cancer Inst., 91, 1548-1556.
50. Herynk,M.H., Stoeltzing,O., Reinmuth,N., Parikh,N.U., Abounader,R., Laterra,J., Radinsky,R., Ellis,L.M. and Gallick,G.E. (2003) Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res., 63, 2990-2996.
51. Kaplan,O., Firon,M., Vivi,A., Navon,G. and Tsarfaty,I. (2000) HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells. Neoplasia, 2, 365-377.
52. Michieli,P., Mazzone,M., Basilico,C., Cavassa,S., Sottile,A., Naldini,L. and Comoglio,P.M. (2004) Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell, 6, 61-73.
53. Bardelli,A., Longati,P., Gramaglia,D., Basilico,C., Tamagnone,L., Giordano,S., Ballinari,D., Michieli,P. and Comoglio,P.M. (1998) Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl Acad. Sci. USA, 95, 14379-14383.
54. Atabey,N., Gao,Y., Yao,Z.J., Breckenridge,D., Soon,L., Soriano,J.V., Burke,T.R.,Jr and Bottaro,D.P. (2001) Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J. Biol. Chem., 276, 14308-14314.